Jean-christophe Renondin - Net Worth and Insider Trading

Jean-christophe Renondin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jean-christophe Renondin owns 1 companies in total, including AgeX Therapeutics Inc (AGE) .

Click here to see the complete history of Jean-christophe Renondin’s form 4 insider trades.

Insider Ownership Summary of Jean-christophe Renondin

Ticker Comapny Transaction Date Type of Owner
AGE AgeX Therapeutics Inc 2023-08-09 director

Jean-christophe Renondin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jean-christophe Renondin Ownership Network

Ownership Network List of Jean-christophe Renondin

No Data

Ownership Network Relation of Jean-christophe Renondin

Insider Network Chart

Jean-christophe Renondin Owned Company Details

What does AgeX Therapeutics Inc do?

Who are the key executives at AgeX Therapeutics Inc?

Jean-christophe Renondin is the director of AgeX Therapeutics Inc. Other key executives at AgeX Therapeutics Inc include director & 10 percent owner Juvenescence Us Corp. , Chief Financial Officer Park Andrea Eun Jae , and director & Chief Executive Officer Michael D West .

AgeX Therapeutics Inc (AGE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AgeX Therapeutics Inc (AGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AgeX Therapeutics Inc (AGE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AgeX Therapeutics Inc (AGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AgeX Therapeutics Inc Insider Transactions

No Available Data

Jean-christophe Renondin Mailing Address

Above is the net worth, insider trading, and ownership report for Jean-christophe Renondin. You might contact Jean-christophe Renondin via mailing address: 505 Park Avenue 14th Floor, New York Ny 10022.